Lirilumab by Bristol-Myers Squibb for Relapsed Multiple Myeloma: Likelihood of Approval

Lirilumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Relapsed Multiple Myeloma. According to GlobalData, Phase II drugs for Relapsed Multiple Myeloma have a 37

Website link :https://adquash.com/news_q.php?str=Lirilumab_by_Bristol-Myers_Squibb_for_Relapsed_Multiple_Myeloma:_Likelihood_of_Approval_1187

DSP-0187 by Jazz Pharmaceuticals for Narcolepsy: Likelihood of Approval

DSP-0187 is under clinical development by Jazz Pharmaceuticals and currently in Phase I for Narcolepsy. According to GlobalData, Phase I drugs for Narcolepsy have an 80% phase transition success rate

Website link :https://adquash.com/news_q.php?str=DSP-0187_by_Jazz_Pharmaceuticals_for_Narcolepsy:_Likelihood_of_Approval_1185

Lirilumab by Bristol-Myers Squibb for Refractory Multiple Myeloma: Likelihood of Approval

Lirilumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Refractory Multiple Myeloma. According to GlobalData, Phase II drugs for Refractory Multiple Myeloma have

Website link :https://adquash.com/news_q.php?str=Lirilumab_by_Bristol-Myers_Squibb_for_Refractory_Multiple_Myeloma:_Likelihood_of_Approval_1186

London’s last traditional seafood stalls and where to find them

Not long after World War I, a man called Isaac Brenner started selling jellied eels on the street in Whitechapel. At some point, Brenner added a sign to his stall that said “Tubby Isaacs”, presuma

Website link :https://adquash.com/news_q.php?str=London’s_last_traditional_seafood_stalls_and_where_to_find_them_494